Changes in the cause of death among HIV positive subjects across Europe: Results from the EuroSIDA study

AIDS

Volumn 16, Issue 12, 2002, Pages 1663-1671

  Mocroft, A ^a   Brettle, R ^b   Kirk, O ^c   Blaxhult, A ^d   Parkin, J M ^e   Antunes, F ^f   Francioli, P ^g   D'Arminio Monforte, A ^h   Fox, Z ^a   Lundgren, J D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c HVIDOVRE HOSPITAL   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f HOSPITAL DE SANTA MARIA   (Portugal)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

AIDS; Cause of death; HAART; Pre AIDS mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; EUROPE; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SIDE EFFECT; SUICIDE; VIRUS INFECTION;

EID: 0037119023     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200208160-00012     Document Type: Article

References (33)

1. Changing patterns of mortality in patients infected with HIV
2. The changing spectrum of AIDS across Europe 1994-1998. Results from the EuroSIDA study
3. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
4. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study
5. Pre-AIDS mortality and its association with HIV disease progression in hemophilic men, injecting drug users and homosexual men
6. Pre-AIDS mortality from natural causes associated with HIV disease progression: Evidence from the European Seroconverter Study among injecting drug users
7. Diagnosis, prediction and natural course of HIV-1 protease inhibitor associated lipodystrophy, hyperlipideamia and diabetes mellitus: A cohort study
8. Severe premature coronary artery disease with protease inhibitors
9. Pre-AIDS deaths in HIV infection related to intravenous drug use
10. Clinical manifestations and predictors of disease progression in drug users with HIV infection
11. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam
12. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users
13. Overall and cause specific mortality in a cohort of homo/bisexual men, injecting drug users, and female partners of HIV-infected men
14. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users
15. Mortality from overdose among injecting drug users recently released from prison: Database linkage study
16. Regional differences in the use of antiretrovirals and primary prophylaxis in 3122 European HIV-infected patients
17. Survival in 2367 zidovudine treated patients according to use of other nucleoside analogue drugs
18. 1993 Revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults
19. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: Lactic Acidosis, risk factors and therapeutic options
20. Staging system for clinical AIDS patients
21. Survival prognosis of HIV-1 infected patients
22. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
23. Impact of protease inhibitors on AIDS defining events and hospitalisations in 10 French AIDS reference centres
24. The changing spectrum of HIV mortality: Analysis of 249 deaths from 1995-1999
25. Is HAART enough?
26. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral therapy
27. AIDS-related opportunistic illnesses after initiation of potent antiretroviral therapy
28. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
29. Two decades of HIV infection in a cohort of haemophilic individuals: Clinical outcomes and response to highly active antiretroviral therapy
30. Mortality from liver cancer and liver disease in homophiliac men and boys in UK given blood products contaminated with Hepatitis C
31. Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996
32. Pre-AIDS mortality in the Edinburgh City Hospital HIV Cohort
33. Regional differences in the presentation of AIDS in Europe